Abstract
Congenital adrenal hyperplasia (CAH) is a family of inherited disorders of adrenal steroidogenesis. Each of these disorders has a characteristic pattern of hormonal abnormalities caused by an inherited deficiency of one of the several enzymes necessary for normal steroid synthesis. The most common form of CAH is caused by a deficiency of the 21-hydroxylase enzyme. Virilization is the foremost clinical symptom of 21-hydroxylase deficiency, as was first documented by the Neapolitan anatomist DeCrecchio in 1865.1 Since his report, numerous investigators have unravelled the mechanism of adrenal steroid synthesis and the associated enzyme defects responsible for CAH. A brief review of the mechanism and regulation of adrenal steroidogenesis is given below to aid in the understanding of the pathophysiology of CAH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Decrecchio L: Sopra un caso di apparenze virile in una donna. Morgagni 7: 1951, 1865
Bongiovanni, AM, Eberlein WR, Goldman AS, et al: Disorders of adrenal steroid biogenesis. Recent Prog Horm Res 23: 375–439, 1967
Finkelstein, M, Shaefer JM: Inborn errors of steroid biosynthesis. Physiol Rev 59: 353–406, 1979
Ganong WF: Neurotransmitters and pituitary function: Regulation of ACTH secretion. FedProc 39: 2923–2930, 1980
New MI, Seaman MP: Secretion rates of Cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 30: 361–371, 1970
Jost A: Embryonic sexual differentiation, in Jones HW, Scott WW (eds): Hermaphroditism, Genital Anomalies and Related Endocrine Disorders, 2nd ed. Baltimore, Williams & Wilkins, 1971, pp 16–64
Josso N, Picard JY, Tran D: The antiMullerian hormone. Recent Prog Horm Res 33: 117–168, 1977
Federman DD: Abnormal Sexual Development. Philadelphia, Saunders, 1968, pp 121–133
Binoux M, Pham-Huu-Trung MT, Gourmelen M, et al: Plasma ACTH in adrenogenital syndrome. Acta Paediatr (Stockh) 61: 269–270, 1972
Wilkins L: Adrenal disorders. II. Congenital virilizing adrenal hyperplasia. Arch Dis Child 37: 231–241, 1962
Rosenbloom AL, Smith DW: Varying expression for salt losing in related patients with congenital adrenal hyperplasia. Pediatrics 38: 215–219, 1966
Muller W, Prader A, Kofler J, et al: Frequency of congenital adrenal hyperplasia. Padiatr Padol 14: 151–155, 1979
Cohen JM: Salt-losing congenital adrenal hyperplasia. Pediatrics 44: 621–622, 1969
Hirschfeld AJ, Fleshman JK: An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo. J Pediatr 75: 492–494, 1969
Pang S, Hotchkiss J, Drash AL, et al: Microfilter paper method for 17α-progesterone radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 1003–1008, 1977
Lorenzen F, Pang S, New MI, et al: Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency). Pediatr Res 13: 1356–1370, 1979
Pang S, Murphey W, Levine LS, et al: A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 55: 413–420, 1982
LaFranchi SH, Murphey WH, Foley TP Jr, et al: Neonatal hypothyroidism detected by the northwest regional screening program. Pediatrics 63: 180–191, 1979
Dupont, B, Oberfield, SE, Smithwick EM, et al: Close genetic linkage between HLA and congenital adrenal hyperplasia (21 -hydroxylase deficiency). Lancet 2: 1309–1311, 1977
Levine LS, Zachmann M, New MI, et al: Genetic mapping of the 21-hydroxylase deficiency gene within the HLA linkage group. N Engl J Med 299: 911–915, 1978
Dupont B, Pollack MS, Levine LS, et al: Congenital adrenal hyperplasia, in Teraski PI (ed): Histocompatibility Testing. Los Angeles, UCLA Tissue Typing Laboratory, 1980, pp 693–706
Gutai JP, Kowarski AA, Migeon CJ: The detection of the heterozygous carrier for congenital adrenal hyperplasia. J Pediatr 90: 924–929, 1970
KnorrD, BidlingmaierF, Butenandt0,etal: Test for heterozygosity of congenital adrenal hyperplasia, in Lee PA, Plot- nick LP, Kowarski AA, Migeon CJ (eds): Congenital Adrenal Hyperplasia. Baltimore, University Park Press, 1977, pp 495–500
Lorenzen F, Pang S, New MI, et al: Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 50: 572–579, 1980
Grosse-Wilde HJ, Weil J, Albert E, et al: Genetic linkage studies between congenital adrenal hyperplasia and the HLA blood group system. Immunogenetics 8: 41–49, 1979
Lejeune-Lenain C, Cantraine F, Dufrasnes, M, et al: An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Clin Endocrinol (Oxf) 12: 525–535, 1980
Newmark S, Dluhy RG, Williams GH, et al: Partial 11- and 21-hydroxylase deficiencies in hirsute women. Am J Obstet Gynecol 127: 594–598, 1977
Rosenwaks Z, Lee PA, Jones GS, et al: An attenuated form of congenital virilizing adrenal hyperplasia. J Clin Endocrinol Metab 49: 335–339, 1979
Kohn B, Levine LS, Pollack MS, et al: Late-onset steroid 21-hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55: 817–827, 1982
New MI, Lorenzen F, Pang S, et al: “Acquired” adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorder as congenital adrenal hyperplasia, J Clin Endocrinol Metab 48: 356–359, 1979
Morillo E, Gardner, LI: Genetics of acquired and congenital adrenal hyperplasia. Lancet 2: 202–203, 1979
Laron Z, Pollack MS, Zamir R, et al: Late onset 21-hydroxylase deficiency and HLA in the Ashkenzai population: A new allele at the 21-hydroxylase locus. Human Immunol 1: 55–66, 1980
Blankstein J, Faiman C, Reyes FI, et al: Adult-onset familiar adrenal 21-hydroxylase deficiency. Am J Med 68: 441–448, 1980
Migeon CJ, Rosen waks, Z, Lee PA, et al: The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 51: 647–649, 1980
Pollack MS, Levine, LS, O’Neill GJ, et al: HLA linkage and B14, DR1, Bfs haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency, Am J Hum Genet 33: 540–550, 1981
New MI, Dupont B, Pang S, et al: An update of congenital adrenal hyperplasia. Recent Prog Horm Res 37: 105–181, 1981
Levine LS, Dupont B, Lorenzen F, et al: Cryptic 21 -hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 51: 1316–1324, 1980
Klouda PT, Harris R, Price DA: HLA and congenital adrenal hyperplasia. Lancet 2: 1046, 1978
Pollack MS, Levine LS, Pang S, et al: Diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet 1: 1107–1108, 1979
Levine, LS, Dupont, B, Lorenzen F, et al: Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 53: 1193–1198, 1981
Jeffcoate TN A, Fliegner JRH, Russell SH, et al: Diagnosis of the adrenogenital syndrome before birth. Lancet 2: 553–555, 1965
New MI, Levine LS: Congenital adrenal hyperplasia, in Harris H, Hirschhorn K (eds): Advances in Human Genetics. New York, Plenum, 1973, pp 251–326
Pang S, Levine LS, Cederqvist LL, et al: Amniotic fluid concentrations of Δ5 and Δ4 steroids in fetuses with congenital adrenal hyperplasia due to 21-hydroxylase deficiency and in anencephalic fetuses. J Clin Endocrinol Metab 51: 223–229, 1980
Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia. Invest Urol 17: 169–175, 1979
Bartter FC, Albright F, Forbes AP, et al: The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: An attempt to explain and correct its disordered hormonal pattern. J Clin Invest 30: 237–251, 1951
Rosier A, Levine LS, Schneider B, et al: The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 500–512, 1977
Korth-Schutz S, Levine LS, New MI: Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. J Clin Endocrinol Metab 42: 117–124, 1976
New MI, Peterson RE: Disorders of aldosterone secretion in childhood. Pediatr Clin North Am 13: 43–58, 1966
New MI, Dupont B, Grumbach K, et al: Congenital adrenal hyperplasia and related conditions, in Stanbury JB, Wyn- gaarden JB, Frederickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, 5th ed. New York, McGraw-Hill, 1982, pp 973–1000
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
New, M.I. (1987). Female Pseudohermaphroditism in 21-Hydroxylase Deficiency. In: Gold, J.J., Josimovich, J.B. (eds) Gynecologic Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2157-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2157-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9272-2
Online ISBN: 978-1-4613-2157-6
eBook Packages: Springer Book Archive